| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C
Seong Kyun Na, Byung-Cheol Song
Clin Mol Hepatol.2019;25(3):234-244.   Published online January 21, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0108
                              
Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
Chung-Feng Huang, Ming-Lung Yu
Clin Mol Hepatol.2019;25(2):168-171.   Published online February 11, 2019     
DOI: https://doi.org/10.3350/cmh.2018.1014
                              
Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
Shinya Sato, Kei Moriya, Masanori Furukawa, Soichiro Saikawa, Tadashi Namisaki, Mitsuteru Kitade, Hideto Kawaratani, Kosuke Kaji, Hiroaki Takaya, Naotaka Shimozato, Yasuhiko Sawada, Kenichiro Seki, Koh Kitagawa, Takemi Akahane, Akira Mitoro, Yasushi Okura, Junichi Yamao, Hitoshi Yoshiji
Clin Mol Hepatol.2019;25(1):65-73.   Published online February 25, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0070
                              
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
Christian Mölleken, Maike Ahrens, Anders Schlosser, Julia Dietz, Martin Eisenacher, Helmut E. Meyer, Wolff Schmiegel, Uffe Holmskov, Christoph Sarrazin, Grith Lykke Sorensen, Barbara Sitek, Thilo Bracht
Clin Mol Hepatol.2019;25(1):42-51.   Published online November 19, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0029
                              Supplementary         Cited By 1
Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals
Soon Young Ko, Won Hyeok Choe
Clin Mol Hepatol.2018;24(4):351-357.   Published online March 16, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0063
                              
Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study
Young Min Kim, Suk Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae, Myeong Jun Song, Ji Woong Jang, Soon Young Ko, Jae Dong Lee
Clin Mol Hepatol.2018;24(3):311-318.   Published online June 4, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0070
                                 Cited By 5
Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling
Pil Soo Sung, Eun Byul Lee, Dong Jun Park, Angelo Lozada, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Clin Mol Hepatol.2018;24(3):302-310.   Published online March 12, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0074
                                 Cited By 3
Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?
Jong Eun Yeon
Clin Mol Hepatol.2018;24(3):294-296.   Published online September 11, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1009
                              
Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL
Jong Eun Yeon
Clin Mol Hepatol.2018;24(3):278-293.   Published online May 2, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1002
                                 Cited By 1
2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
The Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol.2018;24(3):169-229.   Published online August 10, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1004
                                 Cited By 2
Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals
Alessio Strazzulla, Giuseppe Coppolino, Giorgio Settimo Barreca, Innocenza Gentile, Laura Rivoli, Maria Concetta Postorino, Maria Mazzitelli, Giuseppe Greco, Chiara Costa, Vincenzo Pisani, Nadia Marascio, Mariadelina Simeoni, Alfredo Focà, Giorgio Fuiano, Daniela Foti, Elio Gulletta, Carlo Torti
Clin Mol Hepatol.2018;24(2):151-162.   Published online April 24, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0059
                                 Cited By 2
Complete response of advanced hepatocellular carcinoma to sorafenib : another case and a comprehensive review
Tae Suk Kim, Ji Hoon Kim, Baek hui Kim, Young-Sun Lee, Yang Jae Yoo, Seong Hee Kang, Sang-June Suh, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun
Clin Mol Hepatol.2017;23(4):340-346.   Published online June 20, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0070
                                 Cited By 3
Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function
Hyun Phil Shin, Ji-Ae Park, Blaire Burman, Richard A. Kozarek, Asma Siddique
Clin Mol Hepatol.2017;23(4):316-322.   Published online August 22, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0087
                                 Cited By 9
Use of sofosbuvir in chronic kidney disease: Is it necessary?
Tae Seop Lim, Sang Hoon Ahn
Clin Mol Hepatol.2017;23(4):308-310.   Published online September 26, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0109
                                 Cited By 2
Current status of and strategies for hepatitis C control in South Korea
Beom Kyung Kim, Eun Sun Jang, Jeong Han Kim, Soo Young Park, Song Vogue Ahn, Hyung Joon Kim, Do Young Kim
Clin Mol Hepatol.2017;23(3):212-218.   Published online September 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0105
                                 Cited By 7
Current status and strategies for viral hepatitis control in Korea
Dong Hyun Sinn, Eun Ju Cho, Ji Hoon Kim, Do Young Kim, Yoon Jun Kim, Moon Seok Choi
Clin Mol Hepatol.2017;23(3):189-195.   Published online September 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0033
                                 Cited By 5
Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis
Oidov Baatarkhuu, Hye Won Lee, Jacob George, Dashchirev Munkh-Orshikh, Baasankhuu Enkhtuvshin, Sosorbaram Ariunaa, Mohammed Eslam, Sang Hoon Ahn, Kwang-Hyub Han, Do Young Kim
Clin Mol Hepatol.2017;23(2):147-153.   Published online May 2, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0055
                                 Cited By 3
Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study
Kwang Il Seo, Byung Chul Yun, Weiquan James Li, Sang Uk Lee, Byung Hoon Han, Eun Taek Park
Clin Mol Hepatol.2017;23(1):74-79.   Published online March 3, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0052
                                 Cited By 2
Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study
Byeong Wook Cho, Seok Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae
Clin Mol Hepatol.2017;23(1):51-56.   Published online March 16, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0053
                                 Cited By 11
Management of direct antiviral agent failures
María Buti, Rafael Esteban
Clin Mol Hepatol.2016;22(4):432-438.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0107
                                 Cited By 15
Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy
Soon Jae Lee, Yoo-Kyung Cho, Soo-Young Na, Eun Kwang Choi, Sun Jin Boo, Seung Uk Jeong, Hyung Joo Song, Heung Up Kim, Bong Soo Kim, Byung-Cheol Song
Clin Mol Hepatol.2016;22(3):390-395.   Published online August 30, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0050
                                 Cited By 1
Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
Jong Man Kim, Kwang-Woong Lee, Gi-Won Song, Bo-Hyun Jung, Hae Won Lee, Nam-Joon Yi, ChoonHyuck David Kwon, Shin Hwang, Kyung-Suk Suh, Jae-Won Joh, Suk-Koo Lee, Sung-Gyu Lee
Clin Mol Hepatol.2016;22(3):366-371.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0022
                              
Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection
Hee Chul Nam, Hae Lim Lee, Hyun Yang, Myeong Jun Song
Clin Mol Hepatol.2016;22(2):259-266.   Published online June 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0020
                                 Cited By 6
Acute pancreatitis associated with pegylated interferon-alpha-2a therapy in chronic hepatitis C
Jong Wook Choi, June Sung Lee, Woo Hyun Paik, Tae Jun Song, Jung Wook Kim, Won Ki Bae, Kyung-Ah Kim, Jung Gon Kim
Clin Mol Hepatol.2016;22(1):168-171.   Published online March 28, 2016     
DOI: https://doi.org/10.3350/cmh.2016.22.1.168
                                 Cited By 4
KASL clinical practice guidelines: management of hepatitis C
The Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol.2016;22(1):76-139.   Published online March 28, 2016     
DOI: https://doi.org/10.3350/cmh.2016.22.1.76
                                 Cited By 33
Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea
Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
Clin Mol Hepatol.2015;21(4):358-364.   Published online December 24, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.4.358
                                 Cited By 7
Comparison and analysis of the prevalence of hepatitis C virus infection by region in the Republic of Korea during 2005-2012
Hae-Sook Shon, Hwa Young Choi, Jang Rak Kim, So Yeon Ryu, Youn-Jae Lee, Myeong Jin Lee, Hyun Ju Min, Jun Lee, Yeong Jun Song, Moran Ki
Clin Mol Hepatol.2015;21(3):249-256.   Published online September 30, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.3.249
                              Supplementary         Cited By 9
Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea
Suh Yoon Yang, Hyun Woong Lee, Youn Jae Lee, Sung Jae Park, Ki Young Yoo, Hyung Joon Kim
Clin Mol Hepatol.2015;21(2):125-130.   Published online June 26, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.2.125
                                 Cited By 2
Hepatitis C virus infection in patients with hemophilia in Korea: Is antiviral therapy effective and safe?
Woo Sun Rou, Byung Seok Lee
Clin Mol Hepatol.2015;21(2):122-124.   Published online June 26, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.2.122
                              
Hepatitis C virus-induced hepatocellular carcinoma
Nicolas Goossens, Yujin Hoshida
Clin Mol Hepatol.2015;21(2):105-114.   Published online June 26, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.2.105
                                 Cited By 51
1 | 2 | 3 | 4 |
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 78
TOTAL : 230938